Identification of an <i>N</i>-acylated-<sup>D</sup>Arg-Leu-NH<sub>2</sub> Dipeptide as a Highly Selective Neuropeptide FF1 Receptor Antagonist That Potently Prevents Opioid-Induced Hyperalgesia

نویسندگان

چکیده

RFamide-related peptide-3 (RFRP-3) and neuropeptide FF (NPFF) target two different receptor subtypes called FF1 (NPFF1R) FF2 (NPFF2R) that modulate several functions. However, the study of their respective role is severely limited by absence selective blockers. We describe here design a highly NPFF1R antagonist RF3286, which potently blocks RFRP-3-induced hyperalgesia in mice luteinizing hormone release hamsters. then showed pharmacological blockade prevents development fentanyl-induced while preserving its analgesic effect. Altogether, our data indicate RF3286 represents useful tool to involvement NPFF1R/RFRP-3 system functions species. Thanks this compound, we critically involved opioid-induced hyperalgesia, suggesting antagonists might represent promising therapeutic tools improve use opioids treatment chronic pain.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.

Neuropeptide FF (NPFF) has been proposed to play a role in pain modulation, opioid tolerance, and several other physiological processes. However, pharmacological agents that would help define physiological roles for this peptide are still missing. Here we report the discovery of a potent and selective NPFF receptor antagonist, RF9, that can be administered systemically. This compound does not s...

متن کامل

A peripheral, intracerebral, or intrathecal administration of an opioid receptor antagonist blocks illness-induced hyperalgesia in the rat.

We used the tail-flick response of rats to study the role of opioid receptors in illness-induced hyperalgesia. An intraperitoneal injection of lithium chloride (LiCl) produced hyperalgesia that was blocked in a dose-dependent manner by subcutaneous injection of the opioid antagonist naloxone. Neither hyperalgesia nor its blockade by naloxone were due to variations in tail-skin temperature induc...

متن کامل

Opioid-induced hyperalgesia (OIH).

BACKGROUND AND OBJECTIVES Opioids are commonly used for pain control; however, they can cause hyperalgesia. The reason why this can happen is not known. The objective of this review was to describe the mechanisms, factors implicated, and drug modulation. CONTENTS The factors implicated in the development of opioid-induced hyperalgesia (OIH), such as duration of use, dose, and type of opioids ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Medicinal Chemistry

سال: 2021

ISSN: ['0022-2623', '1520-4804']

DOI: https://doi.org/10.1021/acs.jmedchem.1c00256